Promising Treatment Options for Axial Spondyloarthritis: An Overview of Experimental Pharmacological Agents
Hasan Tahir,1,2 Swetha Byravan,3 Armin Fardanesh,4 Arumugam Moorthy3,5 1Department of Rheumatology, Royal Free London NHS Foundation Trust, London, UK; 2Division of Medicine, University College London, London, UK; 3Department of Rheumatology, University Hospitals of Leicester NHS Trust, Leicester, U...
Saved in:
Main Authors: | Tahir H (Author), Byravan S (Author), Fardanesh A (Author), Moorthy A (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2021-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Anti-TNF agents for the treatment of active non-radiographic axial spondyloarthritis
by: I. Olivieri, et al.
Published: (2013) -
Management of Axial Spondyloarthritis – Insights into Upadacitinib
by: Braun J, et al.
Published: (2022) -
The Italian Society for Rheumatology recommendations for the management of axial spondyloarthritis
by: M. Manara, et al.
Published: (2021) -
An appraisal of golimumab in the treatment of severe, active nonradiographic axial spondyloarthritis
by: Paccou J, et al.
Published: (2016) -
Axial Spondyloarthritis: Patient-Reported Impact in Europe
by: Garrido-Cumbrera, Marco, et al.
Published: (2022)